New cancer drugs help Johnson & Johnson edges past profit estimates
Pharma giant overcomes patent expiry of arthritis blockbuster Remicade and fallingmedical device sales
J&J’s profit beat estimates thanks to new cancer drugs
Gains from its acquisition of Swiss biotech Actelion also helped the bottom line
New cancer drugs see Johnson & Johnson lift 2017 profit forecast
Second quarter earnings beat forecasts despite slight fall in pharma division
M&A boost helps European shares stay at one-year high
Financial stocks among main Dublin movers, with Bank of Ireland up 1.5% and Permanent TSB gaining 3.4%
Johnson & Johnson agrees $30bn deal to buy Actelion
Company to become leader in medicines treating rare type of high blood pressure
J&J discussing breaking up Actelion in acquisition
Negotiations between the two companies had ended earlier this month
European stocks drift lower as end-of-year rally fizzles out
Miners and technology shares fall most, while travel and energy shares rise in final week
Twist in Actelion tale as ‘strategic’ talks restart with J&J
Earlier negotiations between pharmaceutical firms ended a week ago without a deal
Actelion shares gain on report of progress in Sanofi talks
Share price had fallen by 7% recently as possible takeover of the firm failed to emerge
European stocks climb to 11-month high
Two-week rally driven by rebound in beaten-down banking shares; dollar pauses
European stocks fall ahead of Federal Reserve meeting to raise rates
Wall Street fluctuates on interest rates rise as Fed says increases will be gradual
Sanofi in talks to acquire biotech Actelion as J&J bows out
Swiss drugmaker Roche also touted as possible buyer for Europe’s largest biotech firm
European stocks recover as bank shares rebound
Trading remains thin ahead of Opec meeting and Italian referendum this weekend
Stocks see modest gains but Opec deal, Italy vote weigh
Doubts persist over oil cartel’s ability to agree output cut as Wednesday meeting nears
Johnson and Johnson makes takeover approach for Actelion
Acquisition would add to the $246bn of pharmaceutical deals announced this year
AstraZeneca pips Actelion to buy ZS Pharma for $2.7 billion
British biopharmaceutical company agrees to buy US biotech company
Lung drug firm Actelion posts first-half operating income dip
Company has predicted 2015 core earnings growth to be in the mid-to-high-teen percentage range
Shares in Diageo rise on bid speculation
Brazilian billionaire Jorge Paulo Lemann is said to be eyeing up drinks group
Swiss biotech Actelion hits record high on potential Shire bid
Shire said to be considering a $18bn takeover of Swiss group to boost rare diseases business
European stocks near seven-year high ahead of Eurogroup meeting
Greek stocks fall as Europe’s finance ministers meet in Brussels to discuss financing for the region’s most indebted state
European stocks decline from seven-year high amid Greece talks
Leaders signal some willingness to compromise on bailout terms for Greece
European healthcare firms hit by US tax threat
Shares in US pharmacy Walgreens also hit as it passes up opportunity for Swiss base
Perrigo cited as acquisition target for inversion strategy
US health-care companies may seek to purchase acquirer of Elan to find tax relief abroad
European shares rebound after black boxes handed over
The pan-European FTSEurofirst 300 index was up 0.7 per cent in early morning trading
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices